US Pharma MarketingNew evidence, FDA approval, and Medicare NTAP status expand Infuse™ bone graft use in TLIF.
The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence
The Next Evolution of TLIF: Where Innovation Meets Clinical Evidence is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive